IP Library › Granted Patent US 12661341
Granted Patent B2
US 12661341 · App. 19/331,536 · Granted Jun 23, 2026

Methods of treating migraine

Inventors: Ramesh Boinpally (Princeton, NJ); Joel Trugman (Hoboken, NJ)
Assignee: Allergan Pharmaceuticals International Limited
A61K31/4375A61K31/496A61K45/06A61P25/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12661341
App. No.
19/331,536
Granted
Jun 23, 2026
Kind
B2
Abstract

The present disclosure provides methods for the treatment of migraine by the administration of atogepant or a pharmaceutically acceptable salt thereof.

Claims (3)

1 . A method for the preventive treatment of migraine in a patient having mild or moderate hepatic impairment, the method comprising orally administering a dose selected from the group consisting of 10 mg, 30 mg, and 60 mg atogepant once daily to the patient.

2 . The method according to claim 1 , wherein the migraine is episodic migraine.

3 . The method according to claim 1 , wherein the migraine is episodic migraine.